Created at	Source	Raw Value	Validated value
July 1, 2022, 3:30 p.m.	usa	hypersensitivity to any of the substances used in the study (citric acid dextrosol 2.2% and unfractionated heparin); previous diagnosis of coagulopathy or thrombophilia; contraindication to the use of unfractionated heparin by the assistant team; risk of citrate poisoning - (lactate> 30mg / dl, rni> 2.5, total bilirubin> 15mg / dl); pregnancy	hypersensitivity to any of the substances used in the study (citric acid dextrosol 2.2% and unfractionated heparin); previous diagnosis of coagulopathy or thrombophilia; contraindication to the use of unfractionated heparin by the assistant team; risk of citrate poisoning - (lactate> 30mg / dl, rni> 2.5, total bilirubin> 15mg / dl); pregnancy
June 10, 2022, 9:30 a.m.	usa	None	None
Oct. 26, 2020, 11:31 p.m.	usa	- hypersensitivity to any of the substances used in the study (citric acid dextrosol 2.2% and unfractionated heparin); - previous diagnosis of coagulopathy or thrombophilia; - contraindication to the use of unfractionated heparin by the assistant team; - risk of citrate poisoning - (lactate> 30mg / dl, rni> 2.5, total bilirubin> 15mg / dl); - pregnancy	- hypersensitivity to any of the substances used in the study (citric acid dextrosol 2.2% and unfractionated heparin); - previous diagnosis of coagulopathy or thrombophilia; - contraindication to the use of unfractionated heparin by the assistant team; - risk of citrate poisoning - (lactate> 30mg / dl, rni> 2.5, total bilirubin> 15mg / dl); - pregnancy